Financial Year |
March 31 2023 |
Monetary Funds |
665,595,659.93 |
Held-for-trading Financial Assets |
-- |
Notes Receivable |
730,552,337.82 |
Accounts Receivable |
595,236,795.61 |
Advances to Suppliers |
169,703,459.45 |
Other Receivables |
86,413,211.15 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
503,224,998.56 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
187,333,274.04 |
Total Current Assets |
2,940,215,606.17 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
-- |
Investment Properties |
-- |
Fixed Assetes |
647,841,370.19 |
Under-construction Projects |
1,676,138,627.06 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
105,288,825.77 |
R&D expenses |
-- |
Goodwill |
-- |
Long-Term Deferred and Prepaid Expenses |
2,678,955.48 |
Deferred Income Tax Assets |
16,660,479.87 |
Other Non-Current Assets |
91,733,933.74 |
Sub-Total of Non-Current Assets |
2,568,599,231.98 |
Total Assets |
5,508,814,838.15 |
Short-Term Loans |
380,150,218.21 |
Trading Financial liabilities |
-- |
Notes Payable |
182,588,280.56 |
Accounts Payable |
552,227,286.25 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
2,371,005.82 |
Taxes Payable |
3,615,525.27 |
Interest Payable |
1,611,250.01 |
Dividend Payable |
-- |
Other payables |
125,730,149.04 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
68,904,359.16 |
Other Current Liabilities |
7,784,155.00 |
Sub-Total of Current Liabilities |
1,331,664,330.37 |
Long-term Loans |
1,213,658,525.49 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
-- |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,243,443,627.22 |
Total Liabilities |
2,575,107,957.59 |
Paid-In Capital(Or Share Stock) |
200,044,649.00 |
Capital Surplus |
1,772,407,076.55 |
Surplus Reserve |
39,678,242.70 |
LESS:Treasury Stock |
-- |
Undistributed Profits |
325,551,420.71 |
Minority Stockholder's Interest |
599,522,757.98 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
2,334,184,122.58 |
Owner's Equity(Stockholder's Equity) |
2,933,706,880.56 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
5,508,814,838.15 |